Skip to main content
CORESTA Meeting, Smoke Science/Product Technology, 2023, Cancun, STPOST 46

Measuring tobacco product experience: CROM adapted from the mCEQ for the assessment of new tobacco products

MAINY N.(1); BAJEC M.(2); ALVES FAVARO M.(3); SALZBERGER T.(4); ROSE J.(5)
(1) JT International SA, Geneva, Switzerland; (2) Bajec Senseworks Consulting, Hamilton, Ontario, Canada; (3) Mapi Research Trust, Lyon, France; (4) Institute for Statistics and Mathematics, Institute for Marketing Management, University of Economics and Business (WU Wien), Vienna, Austria; (5) Rose Research Center, Raleigh, NC, U.S.A.

Originally referred to as the Smoking Effects Inventory (SEI), the self-reported measurement instrument commonly known as the modified Cigarette Evaluation Questionnaire (mCEQ) assesses the reinforcing effects of smoking cigarettes. Like other legacy instruments, the mCEQ has been employed to evaluate the subjective effects of new tobacco product (NTP) use, and further adapted per regulatory recommendations for measures of Tobacco Product Perception and Intention (TPPI) study constructs, i.e., Consumer Reported Outcome Measures (CROM). The objectives of this review were to investigate the development pathway of the mCEQ along with the reported psychometric properties of CROM adapted from the mCEQ for NTP assessment: oral nicotine products (ONP), heated tobacco products (HTP), and electronic nicotine delivery systems (ENDS). Concepts/domains, items, and measurement properties of the Product Evaluation Scale (PES), the Tobacco and Nicotine Product Experience Questionnaire (ToNiPEQ; aka the ABOUT-Product Experience), the mCEQ-C, the mCEQ-E, the mCEQ-N, and the Modified E-Cigarette Evaluation Questionnaire (MECEQ) were extracted and reviewed. Here we provide a unique historical perspective and comparative overview of the mCEQ and subsequent adapted CROM, outlining strengths and limitations inherited from this legacy instrument. The reviewed CROM offer a broad range of options to evaluate the reinforcing effects of using NTP. Key considerations for selection and utilization of optimal CROM to measure subjective effects of NTP use are discussed. In the harm reduction context, appropriate psychometric CROM have the potential to capture critical insights concerning the consumer journey (i.e., from product initiation to product adoption, transition and switching trajectories between products). Characterizing the elements that play a role in delivering a fulfilling and genuinely satisfying product experience could further contribute to evidence generation for regulatory engagement.